Attain Performa™ Left Ventricular (LV) Quadripolar Leads Chronic Performance Study

Medtronic

Status: Completed

Conditions: Heart Failure

Study type: Observational

Funder types: Industry

Identifiers

NCT02294331

Attain Performa™ PAS

Details and patient eligibility

About

Lead survivability will be summarized.

Full description

The purpose of this study is to evaluate long-term performance of the Attain Performa™ LV Leads. This evaluation is based on the number of lead-related complications occurring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the Attain Performa™ LV Leads. This study is conducted within Medtronic's post-market surveillance platform.

Enrollment: 1,900 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Patients who meet all of the following inclusion criteria and do not meet any of the following exclusion criteria are eligible for enrollment.

Inclusion Criteria

• Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
• Patient has or is intended to receive an Attain Performa™ LV lead
• Patient within 30 day post implant enrollment window

Exclusion Criteria

• Patient who is, or is expected to be inaccessible for follow-up
• Patient with exclusion criteria required by local law
• Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results

Trial design

1,900 participants in 1 patient group

Attain Performa™ LV Leads

Description:

Patients who meet all Inclusion criteria and no Exclusion criteria and are implanted with an Attain Performa™ LV lead.